Investigating a Vaccine Against COVID-19

Registry ID

EUCTR2020-001228-32

Source registry

EUCTR

Status

GB - no longer in EU/EEA

Phase

PHASE3

Sponsor

CTRG

Start date

2020-05-04

Last update

2026-08-16

Conditions

• SARS-CoV-2

Summary

To assess efficacy of the candidate ChAdOx1 nCoV-19 against COVID-19 in adults aged 18 years and older. To assess the safety of the candidate vaccine ChAdOx1 nCoV-19 in adults.

Locations

• , , UK

Related clinical trials

• Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
• A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
• Viral Infection of HSPC Impacts Hematopoiesis

View on source registry